{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T09:16:02Z","timestamp":1781946962608,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T00:00:00Z","timestamp":1297987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00702-011-0595-8","type":"journal-article","created":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T15:35:54Z","timestamp":1297956954000},"page":"1065-1069","source":"Crossref","is-referenced-by-count":6,"title":["Preliminary studies of the effects of vascular adhesion protein-1 inhibitors on experimental corneal neovascularization"],"prefix":"10.1007","volume":"118","author":[{"given":"Anna","family":"\u00c9nzs\u00f6ly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Dunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsa","family":"R\u00e9cs\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajnalka","family":"Gy\u0151rffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Marics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Bori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rom\u00e1na","family":"Zelk\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa Di","family":"Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"M\u00e1tyus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,18]]},"reference":[{"key":"595_CR1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.exer.2009.09.005","volume":"90","author":"L Almulki","year":"2010","unstructured":"Almulki L, Noda K, Nakao S, Hisatomi T, Thomas KL, Hafezi-Moghadam A (2010) Localization of vascular adhesion protein-1 (VAP-1) in the human eye. Exp Eye Res 90:26\u201332","journal-title":"Exp Eye Res"},{"key":"595_CR2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/OPTH.S3926","volume":"3","author":"AJ Augustin","year":"2009","unstructured":"Augustin AJ, Scholl S, Kirchhof J (2009) Treatment of neovascular age-related macular degeneration: current therapies. Clin Ophthalmol 3:175\u2013182","journal-title":"Clin Ophthalmol"},{"key":"595_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0008-4182(05)80070-5","volume":"40","author":"MM Brown","year":"2005","unstructured":"Brown MM, Brown GC, Stein JD, Roth Z, Campanella J, Beauchamp GR (2005) Age-related macular degeneration: economic burden and value-based medicine analysis. Can J Ophthalmol 40:277\u2013287","journal-title":"Can J Ophthalmol"},{"key":"595_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249\u2013257","journal-title":"Nature"},{"key":"595_CR5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","volume":"12","author":"J Chang","year":"2001","unstructured":"Chang J, Gabison EE, Kato T, Azar DT (2001) Corneal neovascularization. Curr Opin Ophthalmol 12:242\u2013249","journal-title":"Curr Opin Ophthalmol"},{"key":"595_CR6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.preteyeres.2010.01.002","volume":"29","author":"D Ellenberg","year":"2010","unstructured":"Ellenberg D, Azar DT, Hallak JA, Tobaigy F, Han KY, Jain S, Zhou Z, Chang J (2010) Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res 29:208\u2013248","journal-title":"Prog Retin Eye Res"},{"key":"595_CR7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.4.564","volume":"122","author":"DS Friedman","year":"2004","unstructured":"Friedman DS, O\u2019Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564\u2013572","journal-title":"Arch Ophthalmol"},{"key":"595_CR8","unstructured":"Hafezi-Moghadam A (2009) Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (VAP-1) inhibitor. PCT Int Appl WO2009\/061830"},{"key":"595_CR9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","volume":"43","author":"P Lee","year":"1998","unstructured":"Lee P, Wang CC, Adamis AP (1998) Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 43:245\u2013269","journal-title":"Surv Ophthalmol"},{"key":"595_CR10","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1158\/0008-5472.CAN-09-1205","volume":"69","author":"F Marttila-Ichihara","year":"2009","unstructured":"Marttila-Ichihara F, Auvinen K, Elima K, Jalkanen S, Salmi M (2009) Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1\u00a0+\u00a0CD11b\u00a0+\u00a0myeloid cells into tumors. Cancer Res 69:7875\u20137883","journal-title":"Cancer Res"},{"key":"595_CR11","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.4049\/jimmunol.0901794","volume":"184","author":"F Marttila-Ichihara","year":"2010","unstructured":"Marttila-Ichihara F, Castermans K, Auvinen K, oude Egbrink MGA, Jalkanen S, Griffioen AW, Salmi M (2010) Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice. J Immunol 184:3164\u20133173","journal-title":"J Immunol"},{"key":"595_CR12","unstructured":"M\u00e1tyus P, Magyar K, Pihlavisto M, Gyires K, Haider N, Wang Y, Woda P, Dunkel P, T\u00f3th-Sarudy \u00c9, T\u00far\u00f3s G (2010) Compounds for inhibiting semicarbazide-sensitive amine oxidase (SSAO)\/vascular adhesion protin-1 (VAP-1) and uses thereof for treatment and prevention of diseases. PCT Int Appl WO2010\/029379"},{"key":"595_CR13","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1096\/fj.07-105346","volume":"22","author":"K Noda","year":"2008","unstructured":"Noda K, She H, Nakazawa T, Hisatomi T, Nakao S, Almulki L, Zandi S, Miyahara S, Ito Y, Thomas KL, Garland RC, Miller JW, Gragoudas ES, Mashima Y, Hafezi-Moghadam A (2008a) Vascular adhesion protein-1 blockade suppresses choroidal neovascularization. FASEB J 22:2928\u20132935","journal-title":"FASEB J"},{"key":"595_CR14","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1096\/fj.07-9377com","volume":"22","author":"K Noda","year":"2008","unstructured":"Noda K, Miyahara S, Nakazawa T, Almulki L, Nakao S, Hisatomi T, She H, Thomas KL, Garland RC, Miller JW, Gragoudas ES, Kawai Y, Mashima Y, Hafezi-Moghadam A (2008b) Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis. FASEB J 22:1094\u20131103","journal-title":"FASEB J"},{"key":"595_CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.pharmtox.48.060607.174028","volume":"48","author":"GD Novack","year":"2008","unstructured":"Novack GD (2008) Pharmacotherapy for the treatment of choroidal neovascularization due to age-related macular degeneration. Annu Rev Pharmacol Toxicol 48:61\u201378","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"595_CR16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ajo.2007.06.025","volume":"144","author":"RB Nussenblatt","year":"2007","unstructured":"Nussenblatt RB, Ferris F 3rd (2007) Age-related macular degeneration and the immune response: implications for therapy. Am J Ophthalmol 144:618\u2013626","journal-title":"Am J Ophthalmol"},{"key":"595_CR17","unstructured":"Salmi M, Jalkanen S (2009) Method for inhibiting angiogenesis or for treatment of cancer. PCT Int Appl WO2009\/056671"},{"key":"595_CR18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1124\/jpet.105.089649","volume":"315","author":"LM Salter-Cid","year":"2005","unstructured":"Salter-Cid LM, Wang E, O\u2019Rourke AM, Miller A, Gao H, Huang L, Garcia A, Linnik MD (2005) Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase. J Pharmacol Exp Ther 315:553\u2013562","journal-title":"J Pharmacol Exp Ther"},{"key":"595_CR19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.preteyeres.2007.03.002","volume":"26","author":"UM Schmidt-Erfurth","year":"2007","unstructured":"Schmidt-Erfurth UM, Pruente C (2007) Management of neovascular age-related macular degeneration. Prog Retin Eye Res 26:437\u2013451","journal-title":"Prog Retin Eye Res"},{"key":"595_CR20","first-page":"335","volume":"19","author":"N Shams","year":"2006","unstructured":"Shams N, Ianchulev T (2006) Role of vascular endothelial growth factor in ocular angiogenesis. Ophthalmol Clin North Am 19:335\u2013344","journal-title":"Ophthalmol Clin North Am"},{"key":"595_CR21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1196\/annals.1423.040","volume":"1110","author":"DJ Smith","year":"2007","unstructured":"Smith DJ, Vainio PJ (2007) Targeting vascular adhesion protein-1 to treat autoimmune and inflammatory diseases. Ann NY Acad Sci 1110:382\u2013388","journal-title":"Ann NY Acad Sci"},{"key":"595_CR22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1084\/jem.188.1.17","volume":"188","author":"DJ Smith","year":"1998","unstructured":"Smith DJ, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S (1998) Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med 188:17\u201327","journal-title":"J Exp Med"},{"key":"595_CR24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archopht.118.2.264","volume":"118","author":"LM Weih","year":"2000","unstructured":"Weih LM, VanNewkirk MR, McCarty CA, Taylor HR (2000) Age-specific causes of bilateral visual impairment. Arch Ophthalmol 118:264\u2013269","journal-title":"Arch Ophthalmol"},{"key":"595_CR25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/cmdc.200600245","volume":"2","author":"F Yraola","year":"2007","unstructured":"Yraola F, Albericio F, Royo M (2007) Inhibition of VAP1: quickly gaining ground as an anti-inflammatory therapy. Chem Med Chem 2:173\u2013174","journal-title":"Chem Med Chem"},{"issue":"11","key":"595_CR26","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1167\/iovs.04-1330","volume":"46","author":"Z Zhang","year":"2005","unstructured":"Zhang Z, Ma JX, Gao G, Li C, Luo L, Zhang M, Yang W, Jiang A, Kuang W, Xu L, Chen J, Liu Z (2005) Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization. Invest Ophthalmol Vis Sci 46(11):4062\u20134071","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"595_CR27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0026-2862(87)90085-9","volume":"34","author":"M Ziche","year":"1987","unstructured":"Ziche M, Banchelli G, Caderni G, Raimondi L, Dolara P, Buffoni F (1987) Copper-dependent amine oxidases in angiogenesis induced by prostaglandin E1 (PGE1). Microvasc Res 34:133\u2013136","journal-title":"Microvasc Res"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0595-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-011-0595-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0595-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:25:24Z","timestamp":1559103924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-011-0595-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,18]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["595"],"URL":"https:\/\/doi.org\/10.1007\/s00702-011-0595-8","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,18]]}}}